The Irish Pharmaceutical Healthcare Association welcomes the statement by the HSE confirming that it will fund nine delayed medicines for prescribing to patients.
Thousands of patients in Ireland, with serious conditions ranging from heart disease, cancer and skin condition are being denied access to nine new medicines that are routinely available across Europe.
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the new National Cancer Strategy and highlighted the fact that a timely reimbursement system must be in place if it is to deliver on its objectives.
From 1 July next the cost to the State of 780 medicines, most of which are supplied by member companies of the Irish Pharmaceutical Healthcare Association (IPHA), will fall.
World Immunisation Week was marked today at the Royal College of Physicians in Ireland, (RCPI), by Minister for Health, Simon Harris T.D., who launched a new publication, Vaccines for Life, on behalf of the Irish Pharmaceutical Healthcare Association (IPHA).
The Irish Pharmaceutical Healthcare Association (IPHA) has produced a Guidance on Direct Healthcare Professional Communication (DHPC).
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the decision by the HSE to reimburse new Cystic Fibrosis medicines as evidence of a policy commitment to new patients getting access to new medicines.